Work With Data
search
Try Pro
Profile
user

Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer : a systematic review and economic evaluation

Updated: 19d ago
bookmarkBookmark

Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer : a systematic review and economic evaluation is a book. It was written by Steven Joseph Edwards and published by NIHR Journals Library in 2015.

Key facts

plus See more facts

Extract data

Download datasets about Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer : a systematic review and economic evaluation:

dataset Dataset of books series that contain Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer : a systematic review and economic evaluation:

dataset Dataset of book subjects that contain Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer : a systematic review and economic evaluation:

"Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer : a systematic review and economic evaluation" is one of the books by Steven Joseph Edwards, books by NIHR Journals Library and 2,617,384 books in our database.

Related

Connected or similar to Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer : a systematic review and economic evaluation: .

This dashboard is based on data from: The British Library.

This content is available under the CC BY 4.0 license.